Sidley Austin advised Digma Inc. on the financing. Digma has secured $6 million in Seed funding and launched its continuous feedback platform to enable developers to...
You must be a Standard 1 Year member to access this content.
Goodwin advised Optera on the fundraising. Optera announced the completion of its $12 million Series A funding led by Next Frontier Capital with participation from Blackhorn...
You must be a Standard 1 Year member to access this content.
Goodwin advised Playbook on the deal. Playbook closed its $7 million Series A led by Telstra Ventures, with support from Playbook’s founding venture studio Atomic. Based...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Cubist Inc. on the deal. Cubist Inc. announced its $7 million seed round. The round was led by Polychain Capital, with participation from venture...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Polychain Capital on the deal. Polychain Capital announced its lead investment in SPACE ID’s $10 million strategic funding round, with dao5 also participating. Polychain,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Cruz Foam on the deal. Cruz Foam announced its $18 million Series A funding round. The round was led by Helena, with participation by...
You must be a Standard 1 Year member to access this content.
Goodwin advised nxyz on the deal. Nxyz announced its $40 million Series A financing round. nxyz is a web3 platform that enables lightning-fast data infrastructure for blockchains....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Polychain Capital on the deal. Polychain Capital announced its lead investment in Vespene Energy’s $4.3 million financing round. Polychain Capital is a premier investor...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised at.inc/ on the deal. at.inc/ acted as lead investor in a $4 million dollar seed round in Pluto. The round included Switch Ventures...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Sam Altman on the deal. Sam Altman acted as the lead investor in Hermeus’ $100 million Series B financing round. Sam Altman is...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ventyx on the deal. Ventyx Biosciences, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised New Enterprise Associates (NEA) and Versant Ventures on the deal. 858 Therapeutics announced the completion of a $60 million Series...
You must be a Standard 1 Year member to access this content.
